缺血核心阈值随再灌注时间变化:病例对照研究
本研究比较了血管内取栓后完全再灌注的急性缺血性卒中患者与仅静脉阿替普酶治疗且完全再灌注患者的基线CT灌注缺血核心阈值。取栓患者24小时梗死核心中位数17.3ml小于阿替普酶组的24.3ml(p=0.011),取栓患者最佳阈值rCBF<20%(AUC 0.89;95%CI 0.84,0.94),阿替普酶组仍为rCBF<30%(AUC 0.83;95%CI 0.77,0.85)。
要点
- 取栓患者最佳缺血核心CTP阈值为rCBF<20%,阿替普酶患者为rCBF<30%。
- 取栓组24小时梗死核心中位数17.3ml小于阿替普酶组24.3ml(p=0.011)。
- 快速再灌注患者应采用更严格的rCBF阈值评估缺血核心。
核心结论
- 取栓患者因再灌注更早,可挽救更低CBF的组织,快速再灌注者应使用更严格的rCBF阈值估计缺血核心。
研究设计与样本
- 病例对照研究,从国际卒中灌注成像登记处匹配132例取栓患者与132例仅阿替普酶治疗患者,按年龄、临床严重程度、闭塞部位和基线灌注病变体积匹配。
- 对配准的治疗前CTP和24小时DWI进行基于像素的分析,确定缺血核心的最佳CTP阈值。
主要发现
- 取栓患者24小时梗死核心中位数17.3ml(IQR 11.3-32.8)小于阿替普酶对照组的24.3ml(IQR 16.7-42.2;p=0.011)。
- 取栓患者最佳缺血核心阈值为rCBF<20%(AUC 0.89;95%CI 0.84,0.94)。
- 阿替普酶对照组最佳缺血核心阈值仍为rCBF<30%(AUC 0.83;95%CI 0.77,0.85)。
- 基线NIHSS中位数15(IQR 11-19)、年龄中位数65(IQR 59-80)、静脉治疗时间中位数153分钟(IQR 82-315)组间匹配良好(均p>0.05)。
关键数值与推荐
- 取栓患者采用rCBF<20%作为缺血核心阈值(AUC 0.89;95%CI 0.84,0.94)。
- 仅阿替普酶治疗患者采用rCBF<30%作为缺血核心阈值(AUC 0.83;95%CI 0.77,0.85)。
临床怎么用
- 对于实现快速再灌注的取栓患者,考虑使用更严格的rCBF<20%阈值来估计缺血核心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: We aimed to identify whether acute ischemic stroke patients with known complete reperfusion after thrombectomy had the same baseline computed tomography perfusion (CTP) ischemic core threshold to predict infarction as thrombolysis patients with complete reperfusion. METHODS: Patients who underwent thrombectomy were matched by age, clinical severity, occlusion location, and baseline perfusion lesion volume to patients who were treated with intravenous alteplase alone from the International Stroke Perfusion Imaging Registry. A pixel-based analysis of coregistered pretreatment CTP and 24-hour diffusion-weighted imaging (DWI) was then undertaken to define the optimum CTP thresholds for the ischemic core. RESULTS: There were 132 eligible thrombectomy patients and 132 matched controls treated with alteplase alone. Baseline National Institutes of Health Stroke Scale (median, 15; interquartile range [IQR], 11-19), age (median, 65; IQR, 59-80), and time to intravenous treatment (median, 153 minutes; IQR, 82-315) were well matched (all p > 0.05). Despite similar baseline CTP ischemic core volumes using the previously validated measure (relative cerebral blood flow [rCBF], <30%), thrombectomy patients had a smaller median 24-hour infarct core of 17.3ml (IQR, 11.3-32.8) versus 24.3ml (IQR, 16.7-42.2; p = 0.011) in alteplase-treated controls. As a result, the optimal threshold to define the ischemic core in thrombectomy patients was rCBF <20% (area under the curve [AUC], 0.89; 95% CI, 0.84, 0.94), whereas in alteplase controls the optimal ischemic core threshold remained rCBF <30% (AUC, 0.83; 95% CI, 0.77, 0.85). INTERPRETATION: Thrombectomy salvaged tissue with lower CBF, likely attributed to earlier reperfusion. For patients who achieve rapid reperfusion, a stricter rCBF threshold to estimate the ischemic core should be considered. Ann Neurol 2017;82:995-1003.
引用
- Bivard A, Kleinig T, Miteff F, et al. Ischemic core thresholds change with time to reperfusion: A case control study. Ann Neurol. 2017. PMID: 29205466. doi:10.1002/ana.25109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。